[go: up one dir, main page]

AU2002329438A1 - Methods and animal models for tumor formation involving dutti - Google Patents

Methods and animal models for tumor formation involving dutti

Info

Publication number
AU2002329438A1
AU2002329438A1 AU2002329438A AU2002329438A AU2002329438A1 AU 2002329438 A1 AU2002329438 A1 AU 2002329438A1 AU 2002329438 A AU2002329438 A AU 2002329438A AU 2002329438 A AU2002329438 A AU 2002329438A AU 2002329438 A1 AU2002329438 A1 AU 2002329438A1
Authority
AU
Australia
Prior art keywords
dutti
methods
animal models
tumor formation
formation involving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002329438A
Inventor
Pamela Rabbitts
Terence Howard Rabbitts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0123628A external-priority patent/GB0123628D0/en
Priority claimed from GB0127667A external-priority patent/GB0127667D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2002329438A1 publication Critical patent/AU2002329438A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002329438A 2001-10-02 2002-10-02 Methods and animal models for tumor formation involving dutti Abandoned AU2002329438A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0123628.0 2001-10-02
GB0123628A GB0123628D0 (en) 2001-10-02 2001-10-02 model
GB0127667.4 2001-11-19
GB0127667A GB0127667D0 (en) 2001-11-19 2001-11-19 Model
PCT/GB2002/004447 WO2003029818A2 (en) 2001-10-02 2002-10-02 Methods and animal models for tumor formation involving dutti

Publications (1)

Publication Number Publication Date
AU2002329438A1 true AU2002329438A1 (en) 2003-04-14

Family

ID=26246601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002329438A Abandoned AU2002329438A1 (en) 2001-10-02 2002-10-02 Methods and animal models for tumor formation involving dutti

Country Status (2)

Country Link
AU (1) AU2002329438A1 (en)
WO (1) WO2003029818A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69816467T2 (en) * 1997-10-20 2004-04-15 The Regents Of The University Of California, Oakland ROBO: A FAMILY OF POLYPEPTIDES AND NUCLEIC ACIDS EFFECTIVELY IN NERVOUS LINE
AU740907B2 (en) * 1997-11-14 2001-11-15 Regents Of The University Of California, The Slit polypeptide and method of modulation of robo with ligands

Also Published As

Publication number Publication date
WO2003029818A3 (en) 2003-11-06
WO2003029818A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2003262735A1 (en) Meeting location determination using spatio-semantic modeling
EP1585501A4 (en) Sustained-release preparations and method for producing the same
AU2003224076A1 (en) Antibody combination useful for tumor therapy
AU2002349543A1 (en) Tumor antigens
AUPR544401A0 (en) Animal model for allergy
AU2003279279A1 (en) Methods for developing animal models
AU2002336999A1 (en) Model of autoimmune disease and methods for identifying agents against autoimmune disease
AU2002359694A1 (en) Compounds and methods
AU2002362613A1 (en) Galectins-1-and-4 in tumor development
AU2002334891A1 (en) Tumor targeted photodiagnostic-phototherapeutic agents
AU2002341828A1 (en) Enhanced proteins and methods for their use
AU2002329438A1 (en) Methods and animal models for tumor formation involving dutti
AU2002252048A1 (en) Methods and systems for shellfish farming
AU2004281077A1 (en) Methods and agents for the treatment of cancer
AU2003243748A1 (en) Animal models of prostate cancer and methods for their use
GB0217054D0 (en) Toy animal
AU2002324193A1 (en) Therapeutic insert and therapeutic method
AU2003201546A1 (en) Animal model
AUPR826501A0 (en) Animal model for allergy
AU2002306319A1 (en) Tumor antigen
AU2002363198A1 (en) Tumor antigen
AU2003296952A1 (en) Methods and vectors for making knockout animals
AU2003906588A0 (en) Animal model
AU2002338825A1 (en) Non-human animal model for analysis of the origin and therapy of organ fibrosis
AU2002333144A1 (en) Compositions and methods for selected tumor treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase